Gene regulatory mechanisms in the launch process of T cell development
We’re honoured to welcome Dr. Ellen Rothenberg, Edward B. Lewis Professor of Biology at Caltech, for a special research seminar.
Events
Calendar
- This event has passed.
Industry Leaders Seminar with Dr. Sam Wadsworth – Bioprinted Tissue Therapeutics to Transform the Treatment of Disease
Meeting ID: 693 4383 4453
Passcode: 608808
Location:
Lecture Theatre B1001, Gordon B. Shrum Building (SHRM)
Sam Wadsworth’s Biography:
As Chief Scientific Officer at Aspect Biosystems, Sam is responsible for our scientific innovation and development. He co-founded the company in 2013 and currently leads our technical efforts in developing Bioprinted Tissue Therapeutics as curative therapies for challenging endocrine disorders including primary adrenal insufficiency and type-1-diabetes. Sam has over 15 years of experience leading world-class tissue engineering R&D and is a recognized leader in the field. He has publications in multiple engineered tissue types including airway, skeletal muscle, neuronal, cartilage, liver and pancreas. Prior to Aspect, Sam was a Research Fellow at the UBC Institute for Heart and Lung Innovation at St. Paul’s Hospital where he spearheaded interdisciplinary, cross-Canada research initiatives to engineer complex 3D human airway tissues and developed cell culture media products that have since been successfully commercialized. Sam holds a PhD in Cell Biology from the University of Nottingham.